|
Advertisement | |||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||
| TABLE OF CONTENTS | |||||||||||||||||||||||||||||||||||||||||||||||
| August 2012 Volume 12 Number 8 | |||||||||||||||||||||||||||||||||||||||||||||||
| In this issue
| ||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||||||||
| Advertisement | |||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||
| REVIEWS | Top | ||||||||||||||||||||||||||||||||||||||||||||||
| Cross-presentation by dendritic cells Olivier P. Joffre, Elodie Segura, Ariel Savina & Sebastian Amigorena p557 | doi:10.1038/nri3254 This Review integrates recent evidence regarding the intracellular trafficking pathways involved in cross-presentation into our understanding of the role of cross-presentation in immunity and tolerance. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||||||||
| Lighting the fires within: the cell biology of autoinflammatory diseases Heiyoung Park, Ariel Bulua Bourla, Daniel L. Kastner, Robert A. Colbert & Richard M. Siegel p570 | doi:10.1038/nri3261 Patients with autoinflammatory diseases develop pathological tissue inflammation in the absence of any autoreactive B or T cell responses. Recent studies have shown that defective regulation of pro-inflammatory immune components or protein handling pathways can provoke such autoinflammatory attacks. This Review describes the latest findings in the field and discusses their therapeutic significance. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||||||||
| The immunological life cycle of tuberculosis Joel D. Ernst p581 | doi:10.1038/nri3259 Here, Joel Ernst proposes that there are distinct stages in the immune response to Mycobacterium tuberculosis that form an 'immunological life cycle'. The description of this framework can help the understanding and study of immunity to tuberculosis in humans and animal models. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||||||||
| Recent progress in mucosal vaccine development: potential and limitations Nils Lycke p592 | doi:10.1038/nri3251 This Review summarizes the past, current and future directions for the development of mucosal vaccines, with a particular focus on the importance of the formulation, the route of administration and the choice of adjuvant for the induction of protective mucosal immunity. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||||||||
| PERSPECTIVES | Top | ||||||||||||||||||||||||||||||||||||||||||||||
| OPINION Towards an HIV cure: a global scientific strategy Steven G. Deeks, Brigitte Autran, Ben Berkhout, Monsef Benkirane, Scott Cairns, Nicolas Chomont, Tae-Wook Chun, Melissa Churchill, Michele Di Mascio, Christine Katlama, Alain Lafeuillade, Alan Landay, Michael Lederman, Sharon R. Lewin, Frank Maldarelli, David Margolis, Martin Markowitz, Javier Martinez-Picado, James I. Mullins, John Mellors, Santiago Moreno, Una O'Doherty, Sarah Palmer, Marie-Capucine Penicaud, Matija Peterlin, Guido Poli, Jean-Pierre Routy, Christine Rouzioux, Guido Silvestri, Mario Stevenson, Amalio Telenti, Carine Van Lint, Eric Verdin, Ann Woolfrey, John Zaia & Françoise Barré-Sinoussi for The International AIDS Society Scientific Working Group on HIV Cure p607 | doi:10.1038/nri3262 The development of effective antiretroviral therapies has greatly improved the disease prognosis for patients with HIV. However, the limitations of these therapies have renewed interest in developing alternative treatment strategies. Here, a group of experts from the International AIDS Society discuss the research steps that need to be taken to achieve the ultimate objective — a cure for HIV. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||||||||||||
| Advertisement | |||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||
| *2011 Journal Citation Report (Thomson Reuters, 2012) |
You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount For further technical assistance, please contact our registration department For print subscription enquiries, please contact our subscription department For other enquiries, please contact our feedback department Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |
![]() |











No comments:
Post a Comment